Beendete Studien

• MDS: MEDI D4190C00007

• CML: BMS 180373

• AML: TCP-ATRA

• AML: Bayer 16520

• MDS: BI 1230.33

• Diverse: Biotest 989

• SIADH: Otsuka156-12-203

• AML: Astellas 2215-CL-0101

• AML: AbbVie M14-358

• CCC: PCI Biotech A202/12

• CLL: I.R.I.S CL1-55746-001

• Diverse: EMR 100070-001

• HCC: EMR 200095-005

• MM: Abbvie M14-467

• MM: Celgene Medi4736-MM-001

• MM: Celgene Medi4736-MM-003

• AML: Catapult D-00272-CT2014002

• Diverse: Novartis CINC280A2108

• Diverse: Rigontec RGT 100

• Diverse: BMS CA 209-9GW

• Diverse: Merck EMR 200647-001

• AML/MM: Bayer 18117

• Diverse: Glenmark

• MDS: Philogen PH-F16IL2CD33-03/15

• NHL/ DLBCL: Roche BH39147-NHL-DLBCL

• NHL: Zuma 7

• AML: Novartis CPDR001X2105

• AML: H3 Biomedicine

• MDS: Abbvie M15-522

• Diverse: EMR 100036-002

• Urothel: Daiichi Sankyo DS8201-A-U105

• HNSCC: AstraZeneca D5660C00004

• Diverse: MSD MK4621-002

• MM: MOR202C101

• AML: Army 1

• NHL: JCAR17-BCM-001

• NHL: Blinatumumab 20140286

• MDS: Abbvie M15-531

• Glioblastom: AMG 596